Compounds > meglumine antimoniate
Page last updated: 2024-08-24

meglumine antimoniate and Innate Inflammatory Response

meglumine antimoniate has been researched along with Innate Inflammatory Response in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR1
Bordignon, J; Conchon Costa, I; Costa, IN; da Silva, SS; Fanti, JR; Felipe, I; Mizokami, SS; Pavanelli, WR; Verri, WA1
Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB1
Araújo, EJ; Conchon-Costa, I; da Silva, SS; Fanti, JR; Felipe, I; Kawakami, NY; Miranda, MM; Mizokami, SS; Panis, C; Pavanelli, WR; Sforcin, JM; Teixeira, FH; Verri, WA; Watanabe, MA1
Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M1
Benjelloune, A; Berraho, A; Charif Chefchaouni, M; El Lyacoubi, M; Lamrani, R1

Trials

1 trial(s) available for meglumine antimoniate and Innate Inflammatory Response

ArticleYear
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.
    Infection and immunity, 2002, Volume: 70, Issue:12

    Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome

2002

Other Studies

5 other study(ies) available for meglumine antimoniate and Innate Inflammatory Response

ArticleYear
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
    International immunopharmacology, 2020, Volume: 85

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA

2020
Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain.
    The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:6

    Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin

2018
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
    The American journal of tropical medicine and hygiene, 2014, Volume: 91, Issue:5

    Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult

2014
Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
    Parasitology research, 2016, Volume: 115, Issue:4

    Topics: Animals; Cytokines; Inflammation; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propolis

2016
[Cutaneous leishmaniasis of the lid].
    Journal francais d'ophtalmologie, 2002, Volume: 25, Issue:5

    Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Eyelid Diseases; Female; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds

2002